☰

Andrew X. Zhang - Publications

Affiliations: 
2007-2012 Yale University, New Haven, CT 
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Kaiser C, Rincon Pabon JP, Khowsathit J, Castaldi P, Kazmirski SL, Weis DD, Zhang AX, Karanicolas J. Modulating antibody structure and function through directed mutations and chemical rescue. Acs Synthetic Biology. PMID 29609459 DOI: 10.1021/Acssynbio.8B00124  0.409
2014 McEnaney PJ, Fitzgerald KJ, Zhang AX, Douglass EF, Shan W, Balog A, Kolesnikova MD, Spiegel DA. Chemically synthesized molecules with the targeting and effector functions of antibodies. Journal of the American Chemical Society. 136: 18034-43. PMID 25514603 DOI: 10.1021/Ja509513C  0.698
2012 McEnaney PJ, Parker CG, Zhang AX, Spiegel DA. Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease. Acs Chemical Biology. 7: 1139-51. PMID 22758917 DOI: 10.1021/Cb300119G  0.688
2012 Jakobsche CE, McEnaney PJ, Zhang AX, Spiegel DA. Reprogramming urokinase into an antibody-recruiting anticancer agent. Acs Chemical Biology. 7: 316-21. PMID 22098560 DOI: 10.1021/cb200374e  0.753
2012 Chen WC, Zhang AX, Li SD. Limitations and niches of the active targeting approach for nanoparticle drug delivery European Journal of Nanomedicine. 4: 89-93. DOI: 10.1515/Ejnm-2012-0010  0.319
2012 Zhang AX, Hoimes CJ, Murelli RP, Saltzman WM, Spiegel DA. Abstract 4747: Redirecting the endogenous immune response against prostate cancer using an antibody-recruiting small molecule Cancer Research. 72: 4747-4747. DOI: 10.1158/1538-7445.Am2012-4747  0.757
2010 Zhang AX, Murelli RP, Barinka C, Michel J, Cocleaza A, Jorgensen WL, Lubkowski J, Spiegel DA. A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules. Journal of the American Chemical Society. 132: 12711-6. PMID 20726553 DOI: 10.1021/Ja104591M  0.751
2010 Hoimes CJ, Murelli RP, Kelly WK, Zhang AX, Cheng CJ, Fields RJ, Spiegel DA, Saltzman WM. Effect of vorinostat (V)-loaded PLGA nanoparticles (NP) surface modified with a PSMA ligand on prostate cancer (PC) cells. Journal of Clinical Oncology. 28: e13629-e13629. DOI: 10.1200/Jco.2010.28.15_Suppl.E13629  0.627
2009 Murelli RP, Zhang AX, Michel J, Jorgensen WL, Spiegel DA. Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer. Journal of the American Chemical Society. 131: 17090-2. PMID 19888723 DOI: 10.1021/Ja906844E  0.774
Show low-probability matches.